Alkermes
ALKS
#2840
Rank
A$8.21 B
Marketcap
A$49.29
Share price
-2.18%
Change (1 day)
0.07%
Change (1 year)

Earnings for Alkermes (ALKS)

Earnings in 2025 (TTM): A$0.46 Billion

According to Alkermes's latest financial reports the company's current earnings are A$1.47 Billion. a decrease over its 2024 earnings that were of A$0.67 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Alkermes from 1992 to 2025

Annual earnings

Year Earnings Change
2025 A$0.43 B-34.87%
2024 A$0.67 B-17.97%
2023 A$0.82 B-468.52%
2022 -A$0.23 Billion449.24%
2021 -A$40.62 Million-68.04%
2020 -A$0.13 Billion-52.1%
2019 -A$0.27 Billion64.49%
2018 -A$0.17 Billion-15.04%
2017 -A$0.19 Billion-34.2%
2016 -A$0.29 Billion-5.34%
2015 -A$0.31 Billion35084.97%
2014 -A$0.87 Million
2012 A$10.73 M-117.81%
2011 -A$60.28 Million-12.69%
2010 -A$69.05 Million94.3%
2009 -A$35.54 Million-117.7%
2008 A$0.20 B622.63%
2007 A$27.78 M
2004 -A$0.11 Billion-14.48%
2003 -A$0.13 Billion11.88%
2002 -A$0.12 Billion39.65%
2001 -A$82.24 Million5.73%
2000 -A$77.78 Million-28.91%
1999 -A$0.11 Billion237.28%
1998 -A$32.44 Million100.05%
1997 -A$16.22 Million-37.93%
1996 -A$26.12 Million82.72%
1995 -A$14.3 Million-26.79%
1994 -A$19.53 Million-72.78%
1993 -A$71.74 Million208.07%
1992 -A$23.29 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
A$48.52 B 10,946.76%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
A$23.64 B 5,283.78%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
A$14.73 B 3,255.65%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
A$11.13 B 2,434.94%๐Ÿ‡ซ๐Ÿ‡ท France
Bristol-Myers Squibb
BMY
A$13.49 B 2,971.18%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
A$20.40 B 4,544.96%๐Ÿ‡ฌ๐Ÿ‡ง UK
Zogenix
ZGNX
-A$0.31 Billion-169.81%๐Ÿ‡บ๐Ÿ‡ธ USA
Acorda Therapeutics
ACOR
-A$0.4 Billion-189.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
A$3.11 B 608.53%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel